OverviewChartNewsTraderScreen

JP Morgan Put 310 AMGN 19.07.2024/  DE000JB9EZ59  /

EUWAX
2024-05-02  9:49:23 AM Chg.+0.24 Bid10:00:37 PM Ask10:00:37 PM Underlying Strike price Expiration date Option type
3.45EUR +7.48% -
Bid Size: -		 -
Ask Size: -		 Amgen Inc 310.00 USD 2024-07-19 Put
TeleTrader 05-02 Amgen Q1 revenue jumps 22% to $7.4 billion
TeleTrader 05-02 US surges at close as traders weigh Fed remarks
TeleTrader 05-02 US opens higher, Dow jumps 240 points
GlobeNewswire 05-02 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 05-02 US higher premarket after Fed's decision
GlobeNewswire 05-01 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 04-30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
TeleTrader 04-24 Wall Street opens mostly higher amid earnings jitters
GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire 04-16 Turnstone Biologics Appoints William Waddill to its Board of Directors
GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 04-15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
GlobeNewswire 04-15 Shah Capital nominates two highly qualified independent director candidates for Novavax
GlobeNewswire 04-11 FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
GlobeNewswire 04-09 Opthea Appoints John Han, PharmD, as VP Medical Affairs
GlobeNewswire 04-08 Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual ...
GlobeNewswire 04-08 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 04-05 NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US
GlobeNewswire 04-05 CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US
GlobeNewswire 04-05 NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US
GlobeNewswire 04-04 Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth
GlobeNewswire 04-03 CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engag...
GlobeNewswire 04-02 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer